Literature DB >> 22487989

Synthesis of novel heterobimetallic copper(I) hydrazone Schiff base complexes: a comparative study on the effect of heterocyclic hydrazides towards interaction with DNA/protein, free radical scavenging and cytotoxicity.

Palanisamy Sathyadevi1, Paramasivam Krishnamoorthy, Rachel R Butorac, Alan H Cowley, Nallasamy Dharmaraj.   

Abstract

Two new copper(I) hydrazone complexes have been synthesised from bivalent copper precursor [CuCl(2)(PPh(3))(2)] and ferrocene containing bidentate hydrazone ligands HL(1) (1) or HL(2) (2). Based on the elemental analyses and spectroscopic data, the complexes are best formulated as [CuL(1)(PPh(3))(2)] (3) and [CuL(2)(PPh(3))(2)] (4) of the monovalent copper ion. Solid state structures of ligand 2 and its corresponding complex 4 were also determined. The DNA/albumin interactions of all the synthesised compounds were investigated using absorption, emission and synchronous fluorescence studies. Further, antioxidant properties of all the compounds have also been checked against ABTS, O(2)(-) and OH radicals. Additionally, the in vitro cytotoxic activity of compounds 1-4 was assessed using tumour (HeLa, A431) and non-tumour (NIH 3T3) cell lines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487989     DOI: 10.1039/c2mt00004k

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  9 in total

1.  Design and synergistic effect of nano-sized epoxy-NiCo2O4 nanocomposites for anticorrosion applications.

Authors:  M Swathika; Kshitij Rb Singh; M Mehala; Sadanand Pandey; Jay Singh; Ravindra Pratap Singh; Arunadevi Natarajan
Journal:  RSC Adv       Date:  2022-05-17       Impact factor: 4.036

2.  Copper complexes as prospective anticancer agents: in vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest.

Authors:  Dharmasivam Mahendiran; Sethu Amuthakala; Nattamai S P Bhuvanesh; Raju Senthil Kumar; Aziz Kalilur Rahiman
Journal:  RSC Adv       Date:  2018-05-09       Impact factor: 4.036

3.  Enantiopure copper(II) complex of natural product rosin derivative: DNA binding, DNA cleavage and cytotoxicity.

Authors:  Bao-Li Fei; Bin Yin; Dong-Dong Li; Wu-Shuang Xu; Yang Lu
Journal:  J Biol Inorg Chem       Date:  2016-09-14       Impact factor: 3.358

4.  Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents.

Authors:  Monica Carreira; Rubén Calvo-Sanjuán; Mercedes Sanaú; Isabel Marzo; María Contel
Journal:  Organometallics       Date:  2012-07-25       Impact factor: 3.876

5.  Potential anticancer heterometallic Fe-Au and Fe-Pd agents: initial mechanistic insights.

Authors:  Nicholas Lease; Vadim Vasilevski; Monica Carreira; Andreia de Almeida; Mercedes Sanaú; Pipsa Hirva; Angela Casini; María Contel
Journal:  J Med Chem       Date:  2013-07-02       Impact factor: 7.446

6.  Bioactive Heterometallic CuII-ZnII Complexes with Potential Biomedical Applications.

Authors:  Ishani Majumder; Prateeti Chakraborty; Raquel Álvarez; Myriam Gonzalez-Diaz; Rafael Peláez; Younes Ellahioui; Antonio Bauza; Antonio Frontera; Ennio Zangrando; Santiago Gómez-Ruiz; Debasis Das
Journal:  ACS Omega       Date:  2018-10-17

Review 7.  Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.

Authors:  Manzoor Ahmad Malik; Ovas Ahmad Dar; Parveez Gull; Mohmmad Younus Wani; Athar Adil Hashmi
Journal:  Medchemcomm       Date:  2017-12-06       Impact factor: 3.597

8.  (E)3-2-(1-(2,4-Dihydroxyphenyl)ethyldeneamino)phenyl)-2-methylquinazoline-4(3H)-one Schiff Base and Its Metal Complexes: A New Drug of Choice against Methicillin-Resistant Staphylococcus aureus.

Authors:  K Siddappa; Sunilkumar B Mane; Deene Manikprabhu
Journal:  Bioinorg Chem Appl       Date:  2014-03-09       Impact factor: 7.778

9.  Synthesis of Novel VO(II)-Perimidine Complexes: Spectral, Computational, and Antitumor Studies.

Authors:  Gamil A Al-Hazmi; Khlood S Abou-Melha; Nashwa M El-Metwaly; Kamel A Saleh
Journal:  Bioinorg Chem Appl       Date:  2018-09-06       Impact factor: 7.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.